Latest News
Nanosynth (NNN) Shares Plunged 32% on Discounted Capital Raise
The Nanosynth Group PLC (LON: NNN) share price plunged 31.9% after announcing a placement to raise £0.4 million by issuing 222,222,222 new ordinary shares priced at 0.18p each, representing a 32% discount to yesterday’s closi
EURUSD Price: Euro Rallies As US Politics Weigh on the Dollar
The EURUSD currency pair was trading almost 90 pips during the early American session as the euro rallied against the weaker US dollar following last week’s nonfarm payrolls data and the ISM PMI data, which triggered the US d
Here’s Why SWVL Stock Rallied 186%+ in the First Week of 2023
The Swvl Holdings Corp (NASDAQ: SWVL) has been on a roll during the first week of January, rising about 186%. The rally has left many investors wondering whether it is sustainable and the true reason fueling the rally.
Apexigen (APGN) Stock Jumped 126.8% on Positive Stock Rating
The Apexigen Inc (NASDQ: APGN) stock jumped 126.8% after EF Hutton Acquisition Co. initiated coverage of the stock with an $8.00 price target and a buy rating. The rating was issued on Wednesday, January 4, 2022, reigniting i
Uber Climbs After Piper Sandler Upgrade
Uber's (NYSE: UBER) share price has risen more than 2% premarket after the stock was upgraded to Overweight from Neutral by Piper Sandler.
Luminar ‘Looks Like It’s Heading Under $1’ — Citron Research
Luminar (NASDAQ: LAZR) stock tumbled more than 9% in Friday's session, with Citron Research saying it "looks likes its heading under $1" per share in a tweet.
Poolbeg Pharma Shares Rallied 12.5% on Positive Initial Trial Data
The Poolbeg Pharma PLC (LON: POLB) share price rallied 12.5% after announcing positive results from the initial data analysis from its LPS human challenge trial, which is testing the effectiveness of its POLB 001 drug candida
Piper Sandler Remains On Sidelines For Biogen Shares
Biogen (NASDAQ: BIIB) shares jumped Friday after it was announced that the US Food and Drug Administration (FDA) had granted accelerated approval for the company and Eisai Co's Alzheimer's drug, Leqembi.
Which Companies Are Announcing UK Earnings This Week — January 9
This week we can expect updates from more retailers, which we hope will have also experienced a boost over the Christmas period. Names including JD Sports, Sainsbury, Halfords, and Marks & Spencer are expected to provide
Why Nanoco Shares Plunged 23% on Samsung Settlement Details
The Nanoco Group PLC (LON: NANO) share price plunged 23.3% after revealing more details about its planned settlement with Samsung to avoid the long and tedious litigation process that could have cost it time and money.
Tortilla Mexican Grill Shares Up As FY22 Profit Seen In Line With Expectations
Tortilla Mexican Grill (LON: MEX) shares have edged higher early Monday after it said trading since its last update in early October has been strong, and it sees FY22 revenue and profit in line with market expectations.
DeepVerge Shares Rise As 2022 Revenue Jumps — Slightly Below Expectations
DeepVerge (LON: DVRG) said in a release Monday morning that revenue for 2022 came in below market expectations. The company told investor
Hemogenyx (HEMO) Shares Surged 32.9% on New Antiviral Tech
The Hemogenyx Pharmaceuticals PLC (LON: HEMO) share price surged 32.9% after revealing that it had made significant progress developing its Chimeric Bait Receptor (CBR) platform technology, which can be used to combat multipl
Crypto Gains Post US Employment, Polygon MATIC Price Forecast
The broader cryptocurrency market was mostly higher last Friday and over the weekend in the wake of the release of the US Employment report, and also for the week. Polygon MATIC/USD also rallied, which sets up a more bullish
USDCAD Price: Canadian Dollar Rallies on Upbeat Dec Jobs Data
The USDCAD currency pair was trading down over 100 pips from its daily highs after reversing course during the American session following the release of upbeat Canadian jobs data, which surpassed the US nonfarm payroll data r
Spruce Biosciences (SPRB) Stock Soared 165.6% on a $15M Deal
Spruce Biosciences Inc (NASDAQ: SPRB) stock price soared 165.6% after entering a strategic partnership and exclusive licensing agreement with Kaken Pharmaceuticals to develop and commercialise tildacerfont. The drug treats co
CytomX Therapeutics (CTMX) Stock Rallied 81.6% – Here’s Why
The CytomX Therapeutics Inc (NASDAQ: CTMX) stock price rallied higher after releasing an update about its 2023 priorities and progress in its drug pipeline. The company also announced a $35 million licensing deal with Moderna
Bitcoin and Ethereum Poised into US Employment Report
The two largest cryptocurrencies, Bitcoin (BTC) and Ethereum (ETH), have been marking time in a consolidation range, but with a positive bias, since the holiday season and into early 2023. This leaves these markets poised int
Why Avacta Shares Have Risen 11.8% in the First Week of 2023
The Avacta Group Plc (LON: AVCT) share price has risen 11.8% in the first week of 2023, driven by bullish investor sentiment towards the company. However, opinion about Avacta’s prospects is mixed among analysts and here’s wh
Wells Fargo Believes Bed Bath and Beyond Bankruptcy Filing May Be Imminent
Bed Bath & Beyond (NASDAQ: BBBY) issued a warning about its future on Thursday, stating that a bankruptcy filing is a possibility for the company.
